Indication

Severe pre-eclampsia

Severe pre-eclampsia—clinically classified as pre-eclampsia with severe features—is a life-threatening, multi-system hypertensive disorder that develops in pregnant or postpartum individuals, typically after 20 weeks of gestation. Read more about Severe pre-eclampsia

46 drugs 22 manufacturers

Advertisement

Drugs that treat it

Common Severe pre-eclampsia therapies.

Showing 37–45 of 46 drugs

Filter & compare in the drug finder →Opens the drug finder with Severe pre-eclampsia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Severe pre-eclampsia.

Severe pre-eclampsia—clinically classified as pre-eclampsia with severe features—is a life-threatening, multi-system hypertensive disorder that develops in pregnant or postpartum individuals, typically after 20 weeks of gestation.

Pathophysiologically driven by abnormal placental spiral artery remodeling, systemic endothelial dysfunction, and widespread microvascular hypoperfusion, it primarily compromises the maternal cardiovascular, renal, hepatic, pulmonary, and central nervous systems.

The condition is clinically defined by severe-range hypertension—specifically a systolic blood pressure of 160 mm Hg or higher, or a diastolic blood pressure of 110 mm Hg or higher—and/or evidence of maternal end-organ injury, such as thrombocytopenia, impaired hepatic function, progressive renal insufficiency, pulmonary edema, or persistent neurological symptoms.

Personalize your experience

Follow Severe pre-eclampsia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it